Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Byung-Hyun-
dc.contributor.authorKang, Ka-Won-
dc.contributor.authorJeon, Min Ji-
dc.contributor.authorYu, Eun Sang-
dc.contributor.authorKim, Dae Sik-
dc.contributor.authorChoi, Hojoon-
dc.contributor.authorLee, Se Ryun-
dc.contributor.authorSung, Hwa Jung-
dc.contributor.authorPark, Yong-
dc.contributor.authorChoi, Chul Won-
dc.contributor.authorKim, Byung Soo-
dc.date.accessioned2021-09-02T03:16:36Z-
dc.date.available2021-09-02T03:16:36Z-
dc.date.created2021-06-18-
dc.date.issued2018-11-29-
dc.identifier.issn0006-4971-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/71797-
dc.languageEnglish-
dc.language.isoen-
dc.publisherAMER SOC HEMATOLOGY-
dc.titleSurvival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes-
dc.typeArticle-
dc.contributor.affiliatedAuthorKim, Dae Sik-
dc.contributor.affiliatedAuthorLee, Se Ryun-
dc.identifier.doi10.1182/blood-2018-99-115694-
dc.identifier.wosid000454842800255-
dc.identifier.bibliographicCitationBLOOD, v.132-
dc.relation.isPartOfBLOOD-
dc.citation.titleBLOOD-
dc.citation.volume132-
dc.type.rimsART-
dc.type.docTypeMeeting Abstract-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaHematology-
dc.relation.journalWebOfScienceCategoryHematology-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE